Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Colorectal Neoplasms 4Carcinoma, Renal Cell 4Sarcoma 2Prostatic Neoplasms 2Neoplasm Metastasis 2Castration-resistant Prostate Cancer 2Urologic Neoplasms 1Stomach Neoplasms 1Osteosarcoma 1Lymphatic Metastasis 1Ependymoma 1Colonic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Breast Neoplasms 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

enzalutamide 4abiraterone 2Radiotherapy 2Metastasectomy 2Abiraterone Acetate 2testosterone enanthate 1pembrolizumab 1disitamab vedotin 1dactolisib 1VT-464 1Radium-223 1Radiosurgery 1Prednisone 1NVP-BKM120 1Ketoconazole 1Injections 1Hydrocortisone 1Flutamide 1Cyclophosphamide 1Crizotinib 1Control Groups 1Carboplatin 1Calcitriol 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Castration-resistant Prostate Cancer × Metastasectomy × Clear all
NCT06585007 2024-09-05

MEDCARE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting
246 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04222634 2023-12-07

MEDCARE

Universitaire Ziekenhuizen KU Leuven

Phase NA Active not recruiting
18 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡